Does Integration of Induction Chemotherapy to Concurrent Chemotherapy and Radiotherapy Improve Outcomes for Locally Advanced Head and Neck Cancer? A Retrospective Comparison of Patients Treated on Prospective Clinical Trials
J.J. Caudell(Moffitt Cancer Center), James A. Bonner(University of Alabama at Birmingham), Lisle M. Nabell(Memorial Sloan Kettering Cancer Center), Sharon A. Spencer(University of Alabama at Birmingham), R.M. Meredith(University of Alabama at Birmingham)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2011
Cited by 0
Related Papers
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
|Clinical Cancer Research|2015|477
Head and Neck Cancers, Version 2.2014
|Journal of the National Comprehensive Cancer Network|2014|283
Head and Neck Cancers, Version 1.2015
|Journal of the National Comprehensive Cancer Network|2015|269
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers
|Clinical Cancer Research|2010|250
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|221